Showing results (81-90 of 143) with videos related to
Sort By:
Pageof 15
AIDS Care|February 9, 2010
A qualitative study of participant adherence in a randomized controlled trial of herpes suppressive therapy for HIV prevention in TanzaniaMary L Plummer, Deborah Watson-Jones, Shelley Lees, et al.NPJ Vaccines|December 19, 2025
Immunogenicity of one and two doses of Gardasil®9 in Tanzanian girls in the DoRIS TrialTroy J Kemp, Kathy Baisley, John Changalucha, et al.Journal of Clinical Microbiology|August 13, 2010
Use of acyclovir for suppression of human immunodeficiency virus infection is not associated with genotypic evidence of herpes simplex virus type 2 resistance to acyclovir: analysis of specimens from three phase III trialsDeborah Watson-Jones, Anna Wald, Connie Celum, et al.Journal of Clinical Microbiology|February 26, 2010
Association of schistosomiasis with false-positive HIV test results in an African adolescent populationDean B Everett, Kathy J Baisely, Ruth McNerney, et al.BMC Oral Health|October 2, 2025
Prevalence and risk factors for oral human papillomavirus and Epstein-Barr virus co-infections among sexually active males and females in Ibadan, NigeriaAdeola Fowotade, Deborah Oke, Yusuf Bello, et al.The Journal of Infectious Diseases|March 19, 2010
Long-term impact of acyclovir suppressive therapy on genital and plasma HIV RNA in Tanzanian women: a randomized controlled trialClare Tanton, Helen A Weiss, Mary Rusizoka, et al.The Journal of Animal Ecology|November 21, 2025
Land use gradients drive spatial variation in Lassa fever host communities in the Eastern Province of Sierra LeoneDavid Simons, Rory Gibb, Umaru Bangura, et al.The Journal of Infectious Diseases|September 17, 2002
Syphilis in pregnancy in Tanzania. II. The effectiveness of antenatal syphilis screening and single-dose benzathine penicillin treatment for the prevention of adverse pregnancy outcomesDeborah Watson-Jones, Balthazar Gumodoka, Helen Weiss, et al.The Journal of Infectious Diseases|February 24, 2019
Safety and Immunogenicity of a 2-Dose Heterologous Vaccination Regimen With Ad26.ZEBOV and MVA-BN-Filo Ebola Vaccines: 12-Month Data From a Phase 1 Randomized Clinical Trial in Uganda and TanzaniaZacchaeus Anywaine, Hilary Whitworth, Pontiano Kaleebu, et al.Journal of Clinical Microbiology|February 27, 2009
Suitability of simple human immunodeficiency virus rapid tests in clinical trials in community-based clinic settingsDean B Everett, Kathy Baisley, John Changalucha, et al.Pageof 15